scispace - formally typeset
H

Hossein Baharvand

Researcher at University of Science and Culture

Publications -  487
Citations -  20462

Hossein Baharvand is an academic researcher from University of Science and Culture. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 56, co-authored 454 publications receiving 15081 citations. Previous affiliations of Hossein Baharvand include Avicenna Research Institute & Royan Institute.

Papers
More filters
Journal ArticleDOI

Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, +417 more
TL;DR: The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points.
Journal ArticleDOI

Application of conductive polymers, scaffolds and electrical stimulation for nerve tissue engineering.

TL;DR: By taking into consideration the electrical properties of nerve cells and the effect of electrical stimulation on nerve cells, the most commonly utilized conductive polymers, polypyrrole (PPy) and polyaniline (PANI), along with their design and modifications, thus making them suitable scaffolds for nerve tissue engineering.
Journal ArticleDOI

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

Katherine Amps, +124 more
- 27 Nov 2011 - 
TL;DR: Of these genes, BCL2L1 is a strong candidate for driving culture adaptation of ES cells, and single-nucleotide polymorphism analysis revealed that they included representatives of most major ethnic groups.
Journal ArticleDOI

Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.

TL;DR: The differentiation of hESCs into hepatocyte-like cells within 3D collagen scaffolds containing exogenous growth factors gives rise to cells displaying morphological features, gene expression patterns and metabolic activities characteristic of hepatocytes and may provide a source of differentiated cells for treatment of liver diseases.
Journal Article

Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis

TL;DR: Mesenchymal stem cell transplantation seems to be feasible and safe in the treatment of decompensated liver cirrhosis and the quality of life of all four patients improved by the end of follow-up.